At a Glance
| Property | Value |
|---|---|
| Condition | Post-COVID Syndrome |
| Evidence Level | Moderate |
| Causative Agent | SARS-CoV-2 |
| Treatment Approach | our facility is a multimodal inpatient program, typically spanning two to three weeks |
| Key Takeaway | Post-COVID syndrome affects an estimated 10-30% of infected individuals. Proposed mechanisms include viral persistence, fibrin amyloid microclots impairing microcirculation, latent virus reactivation, and dysautonomia; treatment targets the mechanisms found in each patient. |
Post-COVID syndrome, also called long COVID or post-acute sequelae of SARS-CoV-2 (PASC), affects an estimated 10-30% of people who contract COVID-19. At the time of writing, this represents tens of millions of people worldwide who developed a new chronic illness following a viral infection. Many of them remain without effective treatment.
The condition is real. It is measurable. And for many patients, it is debilitating.
What strikes me about post-COVID, and what shapes our perspective at St. George Hospital, is how much it resembles the post-infectious syndromes our clinic has treated for decades. Fatigue, cognitive dysfunction, autonomic dysregulation, and reactivation of latent viruses make up the clinical picture we see in patients with chronic Lyme disease, after EBV, and with other chronic infections. I grew up watching these patients. COVID-19 is a new trigger for an old pattern.
The Mechanisms
Post-COVID is a syndrome with several contributing mechanisms, and their relative importance varies from patient to patient:

1. Viral Persistence
SARS-CoV-2 RNA and spike protein have been detected in tissues months after acute infection, in the gut, brain, vascular endothelium, and other sites [1]. Whether this represents viable virus or residual antigen is debated. Either way, persistent viral components may keep the immune system activated.
2. Microclots and Endothelial Dysfunction
Dr. Beate Jaeger, who collaborates with our facility, has contributed important research on the role of microclots and endothelial dysfunction in post-COVID. Fibrin amyloid microclots, which resist normal fibrinolysis, trap inflammatory molecules and impair microcirculation. This mechanism is still under investigation, but it may explain many post-COVID symptoms, particularly fatigue and cognitive dysfunction. I discuss this in detail in a dedicated article.
3. Immune Dysregulation
COVID-19 can produce lasting changes in immune function:
- Persistent T cell activation and exhaustion
- Reduced regulatory T cell function
- Elevated inflammatory cytokines (IL-6, TNF-alpha, IFN-gamma) months after infection
- Autoantibody formation (antibodies against the patient’s own tissues)
4. Viral Reactivation
SARS-CoV-2 infection can reactivate latent viruses, particularly EBV, CMV, and HHV-6, that a competent immune system had held in check. In some patients, these reactivated viruses become the primary drivers of ongoing symptoms. See my reactivated viruses article.
5. Autonomic Dysfunction
Dysautonomia is common in post-COVID, particularly postural orthostatic tachycardia syndrome (POTS) and other forms of autonomic nervous system dysregulation. Patients experience heart rate variability, blood pressure instability, exercise intolerance, and temperature regulation problems. A functional medicine protocol, including subtype identification, volume expansion, mast cell stabilization, and vagal rehabilitation, is detailed in our POTS and Dysautonomia treatment guide.
6. Mitochondrial Dysfunction
The metabolic cost of acute COVID and the ongoing immune activation deplete mitochondrial function. Many post-COVID patients present with the same mitochondrial dysfunction and cellular energy profile I see in chronic fatigue syndrome and chronic infection patients.
Our Diagnostic Approach
When a post-COVID patient comes to our hospital, the evaluation covers:
- Inflammatory markers: hsCRP, IL-6, TNF-alpha, ferritin, D-dimer
- Coagulation assessment: fibrinogen, von Willebrand factor, microclot assessment where available
- Immune function: lymphocyte subsets (T cells, B cells, NK cells), immunoglobulin levels, autoantibody screening
- Viral persistence markers: SARS-CoV-2 spike protein assay, nucleocapsid antibodies
- Reactivated virus panel: EBV (VCA IgG/IgM, EBNA, EA-D), CMV, HHV-6
- Mitochondrial function: organic acid testing, lactate/pyruvate ratios
- Autonomic assessment: tilt-table testing or active standing test, heart rate variability
- Hormonal panel: COVID frequently disrupts thyroid and adrenal function
- Micronutrient status: deficiencies are common after severe illness
Our Treatment Program
Post-COVID treatment at our facility is a multimodal inpatient program, typically spanning two to three weeks. The program is individualized based on the diagnostic findings, but common components include:
Addressing Microclots and Endothelial Dysfunction
- Anticoagulation therapy (carefully titrated based on coagulation assessment)
- Apheresis: therapeutic blood filtration to remove microclots, inflammatory mediators, and autoantibodies. See my apheresis article.
- Endothelial support: targeted nutrients and medications that support vascular healing
Immune Modulation
- IV immunoglobulin therapy in selected cases with demonstrated immune dysfunction
- Low-dose immunotherapy approaches
- Low-dose naltrexone (LDN) to suppress microglial overactivation and restore endorphin-mediated immune regulation (see LDN for Long COVID and Post-Viral Fatigue for our full dosing protocol)
- Thymosin alpha-1 (TA-1) to restore T-cell competence and NK cell function in patients with confirmed immune exhaustion on lymphocyte subset testing. The mechanisms and our dosing protocol are detailed in thymosin alpha-1 for long COVID
- Treatment of reactivated viruses when identified
Mitochondrial Rehabilitation
- IV NAD+ therapy
- IHHT (Intermittent Hypoxia-Hyperoxia Training) for mitochondrial biogenesis
- Targeted mitochondrial supplementation (CoQ10, alpha-lipoic acid, B vitamins, magnesium)
- IV nutrient therapy (high-dose vitamin C, glutathione)
Autonomic Support
- Graduated exercise protocols designed for dysautonomic patients
- Hydration and electrolyte optimization
- Pharmacological support where indicated (low-dose beta-blockers, fludrocortisone, or midodrine for POTS)
Detoxification and Anti-Inflammatory Support
- Ozone therapy (as immune modulator and antimicrobial)
- Hepatic support
- Anti-inflammatory supplementation
What I Have Observed
At St. George Hospital, we have treated hundreds of post-COVID patients. The outcomes vary, but the patterns are consistent:
- Patients whose primary mechanism is microclots and endothelial dysfunction tend to respond well to apheresis and anticoagulation
- Patients with significant viral reactivation improve when the reactivated viruses are addressed
- Patients with predominantly mitochondrial dysfunction respond to NAD+ and IHHT protocols
- Patients with autoimmune features often require longer treatment and may benefit from immunomodulatory therapy
The majority of patients experience meaningful improvement. Complete resolution is possible but not universal. Some patients require ongoing management. The best outcomes occur in patients who are treated comprehensively rather than piecemeal, and who address the specific mechanisms driving their individual presentation.
The Bottom Line
Post-COVID is a post-infectious syndrome with identifiable, measurable mechanisms. It is not psychosomatic and not “just anxiety”, and it can respond to targeted treatment when the underlying mechanisms are identified and addressed.
The field is evolving rapidly, and our protocols continue to be refined as new evidence emerges. In our clinical observation, a mechanism-based approach does better than waiting for spontaneous recovery, which for many patients does not come. Controlled trials comparing the two do not yet exist.

References
- Swank Z, et al. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clinical Infectious Diseases. 2023;76(3):e487-e490.
This content is educational and does not constitute medical advice. Post-COVID syndrome requires individualized medical evaluation and treatment.